Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma

Annals of the New York Academy of Sciences

Volumn 1090, Issue , 2006, Pages 18-25

  Baltaziak, Marek ^a   Duraj, Ewa ^a   Koda, Mariusz ^a   Wincewicz, Andrzej ^a   Musiatowicz, Marcin ^a   Kanczuga Koda, Luiza ^a   Szymanska, Magdalena ^a   Lesniewicz, Tomasz ^a   Musiatowicz, Boguslaw ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apoptosis; Bax; Bcl xL; Oral cancer; p53

Indexed keywords

PROTEIN BAX; PROTEIN BCL XL; PROTEIN P53; PROTEIN BCL X;

ADULT; APOPTOSIS; CANCER GROWTH; CHI SQUARE TEST; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TUMOR CELL; ARTICLE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY;

ADULT; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CARCINOMA, SQUAMOUS CELL; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MOUTH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34247605962     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1378.002     Document Type: Conference Paper

References (27)

1. SOTIRIOU, C., P. LOTHAIRE, D. DEQUANTER, et al. 2004. Molecular profiling of head and neck tumors. Curr. Opin. Oncol. 16: 211-214.
2. SULKOWSKA, M., W. FAMULSKI, S. SULKOWSKI, et al. 2003. Correlation between Bcl-2 protein expression and some clinicopathological features of oral squamous cell carcinoma. Pol. J. Pathol. 54: 49-52.
3. REED, J.C. 1998. Bcl-2 family proteins. Oncogene 17: 3225-3236.
4. SULKOWSKA, M., W. FAMULSKI, L. CHYCZEWSKI & S. SULKOWSKI. 2001. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity. Neoplasma 48: 94-98.
5. DE LAURENZI, V. & G. MELINO. 2000. Evolution of functions within the p53/p63/p73 family. Ann. N. Y. Acad. Sci. 926: 90-100.
6. THOR, A.D., D.H. MOORE, S.M. EDGERTON, et al. 1992. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J. Natl. Cancer Inst. 84: 845-855.
7. SILVESTRINI, R., M.G. DAIDONE, E. BENINI, et al. 1996. Validation of p53 accumulation as a predictor of distant metastasis at 10 years of followup in 1400 node-negative breast cancers. Clin. Cancer Res. 2: 2007-2013.
8. KASTRINAKIS, W.V., N. RAMCHURREN, K.M. RIEGER, et al. 1995. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene 11: 647-652.
9. LE, Q.T., N.C. DENKO, & A.J. GIACCIA. 2004. Hypoxic gene expression and metastasis. Cancer Metastasis. Rev. 23: 293-310.
10. TOWNSON, J.L., G.N. NAUMOV & A.F. CHAMBERS. 2003. The role of apoptosis in tumor progression and metastasis. Curr. Mol. Med. 3: 631-642.
11. VIGNESWARAN, N., J. WU, N. NAGARAJ, et al. 2005. Differential susceptibility of metastatic and primary oral cancer cells to TRAIL-induced apoptosis. Int. J. Oncol. 26: 103-112.
12. VILLAR, E., M. REDONDO, I. RODRIGO, et al. 2001. Bcl-2 expression and apoptosis in primary and metastatic breast carcinomas. Tumour Biol. 22: 137-145.
13. GU, B., L. ESPANA, O. MENDEZ, et al. 2004. Organ-selective chemoresistance in metastasis from human breast cancer cells: inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus. Carcinogenesis 25: 2293-2301.
14. FERNANDEZ, Y., L. ESPANA, S. MANAS, et al. 2000. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance. Cell. Death Differ. 7: 350-359.
15. KODA, M., J. RESZEC, M. SULKOWSKA, et al. 2004. Expression of the insulinlike growth factor-I receptor and proapoptotic Bax and Bak proteins in human colorectal cancer. Ann. N. Y. Acad. Sci. 1030: 377-383.
16. SULKOWSKA, M., W. FAMULSKI, A. STASIAK- BARMUTA, et al. 2001. PCNA and p53 expression in relation to clinicopathological features of oral papilloma. Folia Histochem. Cytobiol. 39(Suppl 2): 193-194.
17. NYLANDER, K., E. DABELSTEEN & P.A. HALL. 2000. The p53 molecule and its prognostic role in squamous cell carcinoma of the head and neck. J. Oral Pathol. Med. 29: 413-425.
18. SHAHNAVAZ, S.A., J.A. REGEZI, G. BRADLEY, et al. 2000. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas. J. Pathol. 190: 417-422.
19. ITO, T., S. FUJIEDA, H. TSUZUKI, et al. 1999. Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma. Cancer Lett. 140: 81-91.
20. LIU, C.J., K.W. CHANG, S.Y. CHAO, et al. 2004. The molecular markers for prognostic evaluation of areca-associated buccal squamous cell carcinoma. J. Oral Pathol. Med. 33: 327-334.
21. ALA-AHO, R., R. GRENMAN, P. SETH & V.M. KAHARI. 2002. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Oncogene 21: 1187-1195.
22. FAVIANA, P., L. BOLDRINI, R. SPISNI, et al. 2002. Neoangiogenesis in colon cancer: correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression. Oncol. Rep. 9: 617-620.
23. XIE, X., O.P. CLAUSEN, P. DE ANGELIS & M. BOYSEN. 1999. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 86: 913-920.
24. STAIBANO, S., M.D. MIGNOGNA, L. LO MUZIO, et al. 1998. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity. Hum. Pathol. 29: 1189-1194.
25. KERR, J.F., C.M. WINTERFORD & B.V. HARMON. 1994. Apoptosis. Its significance in cancer and cancer therapy. Cancer 73: 2013-2026.
26. TAKEMURA, K., M. NOGUCHI, K. OGI, et al. 2005. Enhanced Bax in oral SCC in relation to antitumor effects of chemotherapy. J. Oral Pathol. Med. 34: 93-99.
27. NOUTOMI, T., H. CHIBA, M. ITOH, et al. 2002. Bcl-x(L) confers multi-drug resistance in several squamous cell carcinoma cell lines. Oral Oncol. 38: 41-48.